Literature DB >> 24325768

Psychopathological stability of personality disorders in substance abuse patients treated in a therapeutic community.

Esperanza Vergara-Moragues1, Francisco González-Saiz, Oscar M Lozano, Antonio Verdejo García.   

Abstract

The objective of this study is to explore the stability of personality dimensions in a selection of psychoactive substance abuse patients during treatment in therapeutic communities. The baseline assessment was conducted 15 to 20 days from the start of therapeutic community treatment, and the second assessment was conducted 3 months after admission. The Millon Clinical Multiaxial Inventory III was used to assess personality dimensions. At 3 months, a reduction was observed in the mean severity scores of most personality dimensions in both patterns and clinical syndromes. Caution should be exercised when assessing and diagnosing personality disorders in a drug addict population because one must consider the presence of abuse concomitant factors that may erroneously increase the comorbidity of personality disorders and related substance abuse disorders.

Entities:  

Mesh:

Year:  2013        PMID: 24325768     DOI: 10.1080/10550887.2013.854154

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  3 in total

1.  EXPLORING PERSONALITY DIAGNOSIS STABILITY FOLLOWING ACUTE PSYCHOTHERAPY FOR CHRONIC POSTTRAUMATIC STRESS DISORDER.

Authors:  John C Markowitz; Eva Petkova; Tatyana Biyanova; Ke Ding; Eun Jung Suh; Yuval Neria
Journal:  Depress Anxiety       Date:  2015-10-06       Impact factor: 6.505

2.  Neuroticism associated with cocaine-induced psychosis in cocaine-dependent patients: a cross-sectional observational study.

Authors:  Carlos Roncero; Constanza Daigre; Carmen Barral; Elena Ros-Cucurull; Lara Grau-López; Laia Rodríguez-Cintas; Nuria Tarifa; Miguel Casas; Sergi Valero
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

3.  Anxiety and Depression in Drug-Dependent Patients with Cluster C Personality Disorders.

Authors:  Carlos Roncero; Adelia de Miguel; Ascensión Fumero; Alfonso C Abad; Rita Martín; Juan Manuel Bethencourt; Lara Grau-López; Laia Rodríguez-Cintas; Constanza Daigre
Journal:  Front Psychiatry       Date:  2018-02-08       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.